Related by context. All words. (Click for frequent words.) 77 Current Controlled Trials 70 NCT# 69 ClinicalTrials.gov Identifier NCT# 68 #-#-# http:/botanicalgarden.berkeley.edu 68 Zerenex Phase 67 confirmatory Phase IIIb 66 ClinicalTrials.gov identifier NCT# 64 #/#/# Date #/#/# #:#:# 64 GATTEX ® 64 NCT# ClinicalTrials.gov 63 Tornado Alley BMX 61 Clinicaltrials.gov 61 multicentre prospective 61 Clinical Trials Registry 61 #-# www.pardeehospital.org 61 number #/#/# Date 60 ClinicalTrials.gov 60 www.portlandalliance.com 60 Phase III randomized controlled 60 ID NCT# 60 Recurrent Glioblastoma 59 www.hceda.org 59 clinicaltrials.gov 59 ISIN Code GB# 59 http:/www.clinicaltrials.gov 59 lorcaserin Phase 59 number NCT# ClinicalTrials.gov 58 dotMobi domains 58 BR.# 58 multicenter multinational 58 www.ClinicalTrials.gov 58 Randomized controlled 58 TAXUS ARRIVE 58 cluster randomized controlled 58 GATTEX ™ 57 Phase IIIb 57 FundingPost Event Calendar 57 Nissan Pathfinder license plates 57 Osathanondh resigned 57 www.hceda.org thecenter 57 Acute Decompensated Heart Failure 57 Achieves ISO #:# 56 treatment naive genotype 56 #-#-# www.gardenshf.org 56 NSABP B 56 Randomized Evaluation 56 ZYBRESTAT TM 56 fosbretabulin 56 visit https:/www#.gotomeeting.com/register/#Tape Deck 56 REVEAL Registry 56 EnSite Fusion 56 RQi 55 Oral Insulin Capsule 55 Prospective Multicenter 55 multicentre randomized 55 Cervical Cytology 55 Triapine R 55 identifier NCT# 55 www.TradeTheTrend.com 55 Multicenter 54 Kacha camp 54 G#DT 54 www.silvercross.org 54 ICH GCP 54 www.hagerstown.org 54 register.php 54 #/#/# Share code 54 QOPI 54 www.frankbettecenter.org 54 Phase IIb III 54 Online BillPay 54 www.morrishospital.org 54 UPLYSO 54 ACC NCDR 54 crizotinib PF # 54 Phase III multicenter 54 Cardiotoxicity 54 acyclovir Lauriad ® 54 FRM Exam 54 randomized Phase IIb 54 Severe Sepsis 54 Please mention keycode 54 Investigational Drug 54 relapsed MM 54 www.systemc.org 54 Student Orientation Advising 54 Pivotal Phase III 54 BRIM3 53 genomic biomarker 53 assessing T DM1 53 OC# [001] 53 HOW TO REGISTER 53 genotypic resistance 53 Left Ventricular Dysfunction 53 Initiate Phase II 53 CDISC ODM 53 BRIM2 53 prospective multicenter 53 Medullary Thyroid Cancer 53 number #/#/# ISIN 53 thorough QT 53 dose escalation phase 53 Tumor Response 53 placebo controlled Phase III 53 ASSERT 53 Derivatives Clearing Organization 53 www.keithley.com events semconfs 53 phase IIIb 53 obtain PTIN 53 EURIDIS 53 Hospitalized Patients 53 register.html 53 #B [003] 53 acyclovir Lauriad R 53 DPR# 53 Initiate Phase 53 Multicentre 53 http:/www.itexpo.com 53 florbetaben 52 dosage regimens 52 Phase Ib II 52 Refractory Angina 52 Combination REOLYSIN R 52 Initiated Phase 52 multicenter Phase III 52 #/#/# Share Code 52 www.juneau.org parksrec adult 52 number N#CA 52 Multicenter Automatic Defibrillator Implantation 52 Chronic Heart Failure 52 designated HVTN 52 Daptomycin 52 www.strictlyrunning.com 52 LUX Lung 52 REMINYL ® 52 webseminars 52 Aplidin R 52 EVEREST II 52 Diabetic Nephropathy 52 Targretin capsules 52 CIMZIA TM certolizumab pegol 52 PROTEGE 52 Cloretazine 52 Main Outcome Measure 52 Oral Fingolimod 52 call Veronique Maillet 52 Applied Metaphysics 52 SENIORS AEROBICS #:# 52 Prospective Randomized 52 www.butte.edu thetrainingplace 52 www#.gotomeeting.com/register/# 52 HCV Genotype 52 Phase Ib clinical 52 MedLine 51 Hepatotoxicity 51 Randomized Phase II 51 Pre Qualification 51 Decompensated Heart Failure 51 Randomized Double blind 51 CHAMPION PCI 51 Soft Tissue Sarcoma 51 National Oncologic PET 51 PI3K/Akt pathway inhibitor 51 Edge STudy 51 Pyridorin 51 Diabetic Foot Ulcer 51 BOS periodic 51 Carotid 51 COPERNICUS 51 Coronary Artery Bypass Graft 51 Histological 51 Randomised Controlled Trial 51 PREVU x LT 51 Antiepileptic Drug 51 Chronic HCV 51 r hGH 51 budesonide MMX Phase III 51 registration.html 51 EGFR HER2 51 promo code MASH# 51 Outpatient Setting 51 Aortic Dissection 51 Percutaneous Coronary Interventions 51 IS0 #:# 51 Cloretazine ® 51 Phase IIIb clinical 51 Clinical Evaluation 51 Motor Vehicles RMV 51 Authority CIRA 51 http:/www.businesswire.com/ 51 Systemic Lupus Erythematosus SLE 51 Phase III Pivotal 51 myelodysplastic myeloproliferative diseases 51 metastatic GIST 51 prucalopride 51 Raptiva r 51 hukou household 51 HBeAg negative patients 51 www.ewomennetwork.com 51 NCCN.org 51 http:/www.clinicaltrials.gov/ 51 HER2 overexpression 51 See WARNINGS 51 CALGB # [002] 51 www.clinicaltrials.gov 51 Raptiva ® 51 Pivotal Trial 51 Optelecom NKF periodic 51 prospective multicentre 51 GENASIS clinical 51 Phase #b/#a clinical 51 Plaque Psoriasis 51 visit www.enbridge.com investor 51 Relapsing Multiple Sclerosis 51 birth certificate baptismal certificate 51 recurrent glioblastoma multiforme 50 Initiates Phase III 50 REVIVE Diabetes 50 Fondaparinux 50 CAMMS# 50 rALLy 50 Guideline Update 50 galiximab 50 Teva Provides Update 50 Phase III Clinical Trial 50 www.polaris int.com 50 SIEF 50 Arzerra TM 50 RECORD1 50 Late Breaker 50 registrational Phase 50 Drivers Licence 50 novel VDA molecule 50 www.ehxweb.com 50 Pafuramidine 50 Val HeFT 50 www.ctiashow.com 50 eCRF 50 CD ROM Manuals 50 GEDO 50 Randomized Controlled Trials 50 overactive bladder syndrome 50 iodomethane 50 prospective nonrandomized 50 Randomized Clinical Trials 50 Ranolazine 50 Randomized Double Blind 50 Zenvia Phase III 50 Shenzhen Rayes Group 50 Submittal 50 Coronary Revascularization 50 Patient Outcomes 50 blinded randomized controlled 50 Spine Patient Outcomes 50 IE Domain 50 Adverse Event 50 randomized controlled multicenter 50 Warfarin Coumadin 50 duplex ultrasonography 50 trastuzumab DM1 T DM1 50 visiting www.proxibid.com 50 E Tryton 50 polyarticular 50 Secondary efficacy endpoints 50 antiarrhythmic drug 50 OvaRex ® MAb 50 IMPACT DCM 50 Clinical Outcome 50 posttreatment 50 Follicular Lymphoma 50 Ambulatory EHR ensures 50 Outcome Measures 50 http:/www.ccr.gov 50 Pegylated Liposomal Doxorubicin 50 COSIRA trial 50 Demonstrates Positive 50 sex offender Letourneau 50 Confirmatory Phase 50 Patients Receiving 50 Investigational Device 50 pain palliation 50 Initiate Lifesaving Treatment 50 NYS RN 50 www.acteva.com go 50 specified primary endpoint 50 www.evergreenparklibrary.org 50 www.setupevents.com 50 toenail onychomycosis 50 including eniluracil ADH 50 Acute Myocardial Infarction 50 fidaxomicin Phase 49 DAPT Study 49 CATIE AD 49 dot mobi domain 49 Elitek 49 Atherothrombosis 49 certolizumab 49 postapproval 49 MS DRG 49 retrospective cohort 49 MPNs 49 PROMACTA CARES 49 Contraindications 49 visit www.silvercross.org 49 metastatic neuroendocrine tumors 49 haematological 49 ONTARGET 49 evaluating carfilzomib 49 label multicenter randomized 49 Drug Eluting Stent System 49 Packet pickup 49 Pesticide Applicator 49 randomized controlled Phase 49 Pivotal Phase 49 prospective observational cohort 49 Ecallantide 49 Lupuzor TM 49 biliary tract cancer 49 primary dysmenorrhoea 49 Treat Anemia 49 XYOTAX TM 49 See CLINICAL PHARMACOLOGY 49 TELCYTA 49 Erythropoiesis Stimulating Agents ESAs 49 CLARITY TIMI 49 Phase 2b Study 49 Demonstrates Significant 49 JAK2 V#F 49 Percutaneous Coronary Intervention 49 www.pbmi.com 49 Initiates Phase 2b 49 VICTOR E1 49 Sabah Aboud 49 Phase 1a clinical 49 Bioequivalence 49 ICD9 49 Coast Guard merchant mariner 49 multicenter randomized placebo controlled 49 hoFH 49 Multiple Ascending Dose 49 TURBT 49 Ambulatory Blood Pressure 49 chemoradiation therapy 49 double blinded randomized 49 Phase IIA 49 www.Active.com 49 Premarket Approval 49 Amoxicillin PULSYS Phase III 49 www.ingenuity.com 49 #CFR# 49 www.theftc.org 49 securities issuable pursuant 49 Percutaneous Tibial Nerve Stimulation 49 Chronic Renal Failure 49 PRE SURGE 49 NMIBC 49 Antiviral Therapy 49 visit www.TheFTC.org 49 Placebo Controlled Trial 49 DocSite PQRI 49 EQ 5D 49 Dalbavancin 49 MAGE A3 ASCI 49 urine dipstick 49 Receives ISO #:# [002] 49 EXPLORE Xa 49 multicenter Phase II 49 indications contraindications 49 Prolongs Survival 49 ARRT 49 Coronary Angiography 49 successive approximation 49 Notified Bodies 49 Randomized Phase 49 adjunctively 49 liver resection 49 TASKi2 49 PANVAC VF 49 System HCPCS 49 eribulin mesylate 49 :# [002] 49 HIV HCV coinfected 49 www.juneausoccer.com 49 Accelerated Approval 49 www.pmi 49 CPT coding 49 Ann Emerg Med 49 confirmatory clinical 49 Migration Agents 49 ß blockers 49 ChronVac C 48 epoetin alpha 48 cytoreductive nephrectomy 48 Pharmacokinetics PK 48 Myocardial Perfusion Imaging 48 Marketing Authorization Applications 48 visit www.ashrae.org 48 GLOBOCAN 48 Systemic Sclerosis 48 HCV SPRINT 48 Randomized Controlled 48 Hepatitis B Virus 48 Tanespimycin 48 including CE CMDCAS 48 ACLS certification 48 Visit http:/www.stockguru.com/joinfree.html 48 MGd 48 transrectal ultrasound guided 48 www.aiag.org 48 ENDEAVOR IV 48 Data Extraction 48 Tigecycline 48 code mashable 48 Hip Arthroplasty 48 intradermal injections 48 CYT# potent vascular disrupting 48 multicentric 48 Protease Inhibitor 48 MEND CABG 48 Upward Soccer 48 Registry NOPR 48 http:/www.icislor.com/dram/index.htm 48 Bayer HealthCare Onyx Pharmaceuticals 48 Universal Numbering 48 BrachySil TM 48 BEXXAR Therapeutic Regimen 48 PrevOnco 48 IBS C 48 Adjuvant Treatment 48 Visit http:/www.stockguru.com 48 intravesical infusion therapy 48 www.uwyo.edu humanities 48 mg/m2 cohort 48 prospective observational studies 48 biologic DMARD 48 Prostate Screening 48 Prostate AdenoCarcinoma Treatment 48 ALT flares 48 ZOSTAVAX 48 Chronic Prostatitis 48 ritonavir boosted protease inhibitor 48 G CSFs 48 Castration Resistant Prostate Cancer 48 atherosclerotic renal artery stenosis 48 ALN HPN 48 Embolic Protection Device 48 CDISC standards 48 ICMJE 48 MDRs 48 ME domains 48 entitled Synergistic 48 Eligibility Requirements 48 Infarct 48 Medicare EHR Incentive 48 NO# [002] 48 cystoscopic 48 med.com 48 Arch Intern Med 48 FDA Investigational Device 48 phase IIb clinical 48 AGHD 48 MERLIN TIMI 48 Successfully Completes Phase 48 Insulin Therapy 48 event visit www.zenithinfotech.com 48 Randomized Phase III 48 Novel Oral 48 MYCAMINE 48 TCVN Forum 48 SafeNet periodic 48 Physical Exams 48 prospectively enrolled 48 Carotid Artery Stenting 48 Transdermal Delivery 48 Pooled Analysis 48 G# [006] 48 NeuroStar TMS Therapy 48 vaccinations microchip 48 SIMPONI TM 48 Sorafenib HCC Assessment 48 visit www.portlandalliance.com 48 Kaplan Meier estimates 48 codes #-# 48 Clinical Trial Evaluating 48 RAPIDGate 48 Earns ISO #:# 48 BEVERLY HILLS YOUTH FOOTBALL 48 gastrointestinal stromal tumors GIST 48 riociguat 48 PHASE III 48 PUBMED 48 clinicaltrials 48 TRANSFORMS 48 www.epeat.net 48 STENT 48 enzyme immunoassay EIA 48 Eligibility criteria 48 receptor tyrosine kinase inhibitor 48 Sipuleucel T 48 Medication Adherence 48 Constructionline 48 ongoing Phase 1b 48 Adjunctive Therapy 48 Standardised 48 Treatment Experienced 48 Medicaid EHR Incentive 48 www.signmeup.com/# 48 hematological parameters 48 Alpha Tocopherol Beta Carotene 48 www.belairnetworks.com webcasts 48 HSCR 48 Societies RoS 48 R lenalidomide 48 tigecycline 48 Modifiable 48 Testosterone MDTS ® 48 Proellex TM 48 www.urban 48 Phase III ThermoDox 48 Mammography Screening 48 Apoptotic 48 Parathyroid Hormone 48 TLK# 48 NABTT 48 Eligibility Verification 48 Matrix Phase 2b 48 Tenderers 48 TAXUS ATLAS 48 k Premarket Notification 48 VP# [004] 48 Initiate Clinical Trial 48 Receives ONC ATCB 48 fallopian tube cancers 48 Calcium Acetate 48 Exelixis XL# 48 ORAL Sync 48 urothelial carcinoma 47 haematopoietic stem cell 47 PERSEUS 47 Pharmacokinetic Study 47 ASTEROID 47 visit www.camdencountylibrary.org events 47 Initiates Clinical 47 http:/www.cbgarden.org 47 Xelox 47 LIST OF FIGURES 47 www.regonline.com 47 CMDCAS 47 Impac Software 47 DIRECT Trial 47 ON #.Na 47 Prescribing Information 47 alpha antagonist 47 Intracerebral Hemorrhage 47 Differential Diagnosis 47 Renal Cancer 47 Patient Registry 47 SNT MC# 47 Myocardial Perfusion 47 Threat eBook 47 Intra Arterial 47 CaPSURE 47 Combination Treatment 47 PFO migraine 47 visit chplnj.org 47 autologous SCT 47 National Provider Identifier 47 Maven Semantic 47 retrospective observational study 47 subcutaneous immunoglobulin 47 EASE Program 47 Pneumococcal Vaccine 47 HSCT 47 SANTE 47 ALTROPANE 47 DMEPOS supplier 47 RoACTEMRA 47 Schizophrenia Treatment 47 events semconfs webseminars 47 Randomized Double Blind Placebo 47 ABSORB clinical 47 key.process 47 Faropenem 47 pelvic lymphadenectomy 47 phase IIb study 47 bronchogenic carcinoma 47 Hedgehog Pathway Inhibitor 47 ThermoDox ® clinical 47 HBeAg + 47 Achieves ISO 47 prospective multicenter study 47 XOMA 3AB 47 Acute Renal Failure 47 cardiac repolarization 47 Adenomas 47 TO AVOID PREGNANCY WHILE 47 FDG PET scans 47 discount code mashable 47 Biometric Identification 47 prasterone 47 sd.org 47 www.phtcorp.com 47 osteopathic manipulative treatment 47 Watchful Waiting 47 SCRAWL 47 Phase IIb Trial 47 IN PATIENTS WITH 47 Brentuximab Vedotin SGN 47 percutaneous transluminal coronary angioplasty 47 YOUTH VOLLEYBALL 47 ara C 47 Approvable 47 nz domain name 47 www.fairfieldpubliclibrary.org 47 Lipsovir ® 47 Pivotal Study 47 ug dose 47 Study Shows Benefits 47 Metastatic Melanoma 47 CT Angiography 47 Catheter Associated 47 Randomized Clinical Trial 47 hepatorenal syndrome 47 Peyronie disease bother 47 Randomization 47 de novo AML 47 Therapy Evaluation 47 OHQ 47 Organ Replacement 47 www.fairfaxcounty.gov rec 47 Interferon Alfa 47 #/team [001] 47 pharmacodynamic parameters 47 Carotid Stenting 47 haematologic 47 USpella 47 BMC Musculoskeletal Disorders 47 toxigenic Clostridium difficile 47 SF #v# 47 Risk Stratification 47 placebo controlled clinical 47 J Clin Oncol 47 ISTODAX 47 rFVIIa 47 Xanafide 47 Scott Ciosek 47 PEARL SC 47 3GPP TS #.# 47 Post Operative 47 Immunosuppression 47 Controlled Trial 47 Immunosuppressant 47 DaTscan 47 CPR AED Adult 47 EPDS 47 Advanced Renal Cell 47 Initiates Phase II 47 visit sbdc 47 proton MR spectroscopy 47 Acute Ischemic Stroke 47 hematopoietic cancers 47 BLS ACLS 47 Antisoma AS# 47 ALN TTR 47 Renal Cell Carcinoma RCC 47 Admit Card 47 Enzastaurin 47 malignant ascites 47 Histologic 47 Hypotension 47 Critically Ill Patients 47 Golimumab 47 Truvada tablets 47 Serious Adverse Events 47 email sbarnes@novaknowledge.ns.ca 47 http:/www.ncbi.nlm.nih.gov/pubmed/# 47 PDX pralatrexate 47 Simulect 47 Lookup Search 47 ARIXTRA R 47 Intravenous immunoglobulin 47 Certican 47 Triapine 47 randomized Phase III 47 recurrent NSCLC 47 Cervical Dysplasia 47 Diabetic Neuropathy 47 CIMYM 47 β blockers 47 #-# [020] 47 Orthostatic Hypotension 47 LEAPS H#N# 47 QT Prolongation 47 Autologous Stem Cell Transplantation 47 IMPROVE HF 47 ISIN Number 47 Aromatase Inhibitors 47 Hepatocellular Carcinoma 47 Credit Debit Card 47 ExTRACT TIMI 47 Libertyville Mundelein Vernon 47 laparoscopic radical nephrectomy 47 Endovascular Valve Edge 47 Applicants MUST 47 DUNS number 47 Ann Intern Med 46 T1DM 46 Ejari 46 randomized controlled trials RCTs 46 Seasonal Influenza 46 tumor histology 46 invasive aspergillosis 46 Clinical Trial Results 46 Double Blind Placebo 46 PROTECT AF 46 A# [002] 46 Competency Assessment 46 BETAS 46 Patient Enrolment 46 Trial Evaluating 46 Xpress Recruitment 46 TMC# C# 46 www.ecri.org 46 Skin Lesions 46 CARE HF 46 Licensing Dep't 46 pulmonary hypertension PH 46 LibiGel ® 46 Shows Efficacy 46 Policies Procedures 46 IMS MIDAS 46 Cloretazine VNP#M 46 ANCHOR trial 46 Ischemic Stroke 46 Readmission 46 EmbraceAC 46 Pressure Monitoring 46 Evoltra ® 46 BPS IC 46 www.elections.org.nz 46 Meets Primary Endpoint 46 Phase IIb Clinical Trial 46 clinico pathological 46 Infusion Reactions Severe 46 Trovax 46 Centralized Procedure 46 Elagolix 46 antiepileptics 46 ARCOXIA 46 quadrivalent human papillomavirus 46 website www.frontieroil.com 46 Reduced Risk 46 preclinical efficacy 46 Minimum Qualifications 46 FluCAM arm 46 Eastwood Optimist 46 registration 46 Arch Surg 46 Accelerated Partial Breast Irradiation 46 antiplatelet medications 46 Heart Transplant Recipients 46 heparin induced thrombocytopenia 46 Nuvelo Announces 46 Initiates Enrollment 46 Computed Tomographic 46 INITIATE 46 Package Insert 46 acetonide FA 46 PROVENGE ® 46 intracranial hemorrhage ICH 46 lipid lowering agents 46 RREs 46 Artelon ® 46 MIVI III 46 Pharmacy OneSource Announces 46 CURRENT OASIS 7 46 J Pediatr 46 longitudinal cohort 46 ADVEXIN therapy 46 HDAC Inhibitor 46 Inflammatory Pain 46 orphan medicinal 46 visit www.isa.org 46 J Virol 46 Data Suggest 46 histopathological 46 Erythropoietic 46 Clinical Practice Guideline 46 Diastolic Heart Failure 46 controlled multicenter Phase 46 syndromic 46 Hormone Refractory Prostate Cancer 46 catheter occlusion 46 Investigational Treatment 46 www.enterprisectr.org 46 Multicenter Phase 46 ST Segment Elevation 46 Tribunale di Firenze 46 PTINs 46 SPRYCEL ® 46 Certifications Application ORCA 46 XL# SAR# 46 .com .net 46 registra tion 46 histological subtype 46 metastatic malignant 46 Study Evaluating 46 please visit www.knowledgecongress.org 46 lymphoid malignancies 46 NDA Submission 46 http:/www.americanregistry.com 46 Psychopharmacol Bull 46 multicenter placebo controlled 46 visit www.marrow.org 46 DEADLINE TO 46 ACZ# 46 Files IND 46 KEGG 46 Clostridium difficile Infection 46 Comorbidity 46 tumor necrosis 46 clinicopathologic 46 Fibromyalgia Impact Questionnaire 46 ISO #:# QMS 46 thetreatment 46 Anticoagulant 46 papillary renal cell carcinoma 46 OvaRex MAb 46 Pre Qualification Questionnaire 46 Int Clin Psychopharmacol 46 CourseMill LMS software 46 colesevelam HCl 46 pretransplant 46 BUPHENYL R 46 www.wiltonlibrary.org events 46 Radiologic Technologists ARRT 46 TLR antagonist 46 Kidney Int 46 serum HCV RNA 46 trastuzumab Herceptin ® 46 retinal vein occlusion induced 46 OPPS 46 IRESSA 46 Completes Patient Enrollment 46 Phase IIa Clinical Trial 46 EHR Incentive Programs 46 www.dfwama.com 46 HKSCC 46 #C [002] 46 number #/#/# JSE 46 refractory chronic lymphocytic 46 btcbridgette@cableone.net 46 RESTORE CLI 46 Progressive Multifocal Leukoencephalopathy 46 accredited registrar 46 mg administered orally 46 Pikesville Rec 46 Pemetrexed 46 Murfreesboro Half Marathon 46 Cellegesic 46 NeoDisc 46 cisplatin gemcitabine 46 About GigaMedia GigaMedia 46 Seasonal Influenza Vaccine 46 INDOOR SOCCER 46 J Am Coll 46 Emerging Therapies 46 brivanib 46 histamine dihydrochloride 46 chemotherapy induced neutropenia 46 Patients Treated With 46 cn domain 46 Utilization Project HCUP 46 ENESTnd 46 ANN INTERN MED 46 baseline LDH 46 P# [002] 46 REACH Compliance 46 Treating Chronic 46 neutering deworming 46 Hepatocellular Carcinoma HCC 46 urine cytology 46 Allogeneic 46 e HEALING 46 vertebral compression fracture 46 Cell Lymphoma 46 interstitial brachytherapy 46 Medicare Beneficiary 46 https:/www.theconferencingservice.com/prereg/key.Rocco Galati 46 visit www.griefandhealing.org 46 gene expression assays 46 IVDs 46 HDL Selective Delipidation 46 CDASH 46 INTERMACS 46 Advanced Melanoma 46 Achieves Primary Endpoint 46 Surgical Procedures 46 http:/www.bmpsunstone.com 46 Acute Coronary Syndromes ACS 46 Biomoda CyPath ® 46 Hormonal Contraceptives 46 tipranavir ritonavir 46 transthyretin TTR mediated amyloidosis 46 Vascugel ® 46 Complicated Skin 46 Cancer Incidence Mortality 45 Estrogen Receptor 45 cytomegalovirus infection 45 Kidney Function 45 TAFA# 45 Granted Orphan Drug 45 cMET 45 non nucleoside 45 Common Procedure Coding 45 Marketing Authorizations 45 achieved CCyR 45 Physician referral 45 Submission Guidelines 45 intraepithelial neoplasia 45 cobas HPV Test 45 cystic fibrosis bronchiectasis 45 antimuscarinic 45 non nucleoside HCV 45 lexidronam injection 45 reregistration 45 Glufosfamide 45 Unstable Angina 45 liveauctioneers.com warrant 45 CATANIA TM stent 45 AFRS TM 45 code MASH# 45 www.coolrunning.com 45 mckeegarden.org 45 PD2i CA 45 Catheter Ablation 45 Chemokine Receptor 45 Enhanced Disclosure 45 percutaneous vertebroplasty 45 Pharmacoeconomic 45 anagrelide 45 Postdoctoral Position 45 Completes Enrollment 45 Alliston Sporting Goods 45 CPE Sponsors 45 BOXED WARNING 45 observational cohort study 45 2 inhibitor CYT# 45 IDET 45 AND CHEER 45 tiuxetan 45 dasatinib Sprycel ® 45 Online Representations 45 pharmacokinetic pharmacodynamic 45 Susceptibility Testing 45 training.com 45 DEXA scan 45 biometrical 45 PRECISE 45 calcaneal fractures 45 Tyrosine Kinase Inhibitor 45 SHIRE PLC 45 OVA1 ® 45 CRA Charities 45 MC FP 45 endothelin receptor antagonists 45 Cardiac Allograft Rejection 45 adefovir treated 45 DIAGNOSTIC 45 HITE SAUNDERS LITTLE LEAGUE 45 Predict Risk 45 Phase 2b Clinical Trial 45 allogeneic hematopoietic stem cell 45 NSF ISR 45 ANSI ESD S#.# 45 Poster Discussion 45 NDTI 45 www.itexpo.com 45 neuro musculoskeletal 45 colorectal carcinomas 45 Am J Epidemiol 45 Receives CE Marking 45 Quality Indicators 45 myelofibrosis MF 45 Berinert 45 www.orosha.org 45 HES CEL 45 adult chronic ITP 45 # # [010] 45 GigaMedia Limited Singapore 45 Liver Fibrosis 45 delipidation 45 Tryout fee 45 cytotoxic conjugate 45 Sanvar R 45 rALLy clinical trial 45 please visit www.advaxis.com 45 FDA APPROVES 45 intravenous tissue plasminogen